E
Sell
5/29/2024Downgrade
Envoy Medical, Inc. (COCH) was downgraded to E+ from D- on 5/29/2024 due to a significant decline in the solvency index, growth index and efficiency index. Total capital declined 71.42% from -$1.2M to -$2.06M, total revenue declined 37.89% from $95 to $59, and earnings per share declined from -$0.248 to -$0.32.
D
Sell
4/3/2024Upgraded
Envoy Medical, Inc. (COCH) was upgraded to D- from E+ on 4/3/2024 due to an increase in the total return index, volatility index and valuation index.
E
Sell
3/19/2024Downgrade
Envoy Medical, Inc. (COCH) was downgraded to E+ from D- on 3/19/2024 due to a decline in the volatility index and valuation index.
D
Sell
3/4/2024Upgraded
Envoy Medical, Inc. (COCH) was upgraded to D- from E+ on 3/4/2024 due to an increase in the volatility index, valuation index and growth index.
E
Sell
12/4/2023Downgrade
Envoy Medical, Inc. (COCH) was downgraded to E+ from D- on 12/4/2023 due to a decline in the valuation index, total return index and volatility index.
D
Sell
11/17/2023Upgraded
Envoy Medical, Inc. (COCH) was upgraded to D- from E on 11/17/2023 due to a significant increase in the solvency index, growth index and efficiency index. The quick ratio increased from 0.03 to 0.63, total capital increased 321.55% from -$3.09M to $6.85M, and earnings per share increased from -$0.0908 to $0.1252.
E
Sell
10/20/2023None
Envoy Medical, Inc. (COCH) was downgraded to E from U on 10/20/2023.
